Work

When “Fibrotic” Does Not Mean Progressive: Interpreting a Trial of Nintedanib in Post-COVID-19 Lung Disease

Year: 2026

Type: article

Source: Annals of the American Thoracic Society

DOI: 10.1093/annalsats/aaoag201

Author: Mark G Jones

Institutions: National Institute for Health and Care Research, NIHR Southampton Respiratory Biomedical Research Unit, University of Southampton

Language: English

Topic: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7169557971

FWCI:

Cites:

Cited by:

Related to: